Multilineage involvement in KMT2A‐rearranged B acute lymphoblastic leukaemia: cell‐of‐origin, biology, and clinical implications

Abstract

AimsB lymphoblastic leukaemia/lymphoma (B‐ALL) is thought to originate from Pro/Pre‐B cells and the genetic aberrations largely reside in lymphoid‐committed cells. A recent study demonstrated that a proportion of paediatric B‐ALL patients have BCR::ABL1 fusion in myeloid cells, suggesting a chronic myeloid leukaemia (CML)‐like biology in this peculiar subset of B‐ALL, although it is not entirely clear if the CD19‐negative precursor compartment is a source of the myeloid cells. Moreover, the observation has not yet been extended to other fusion‐driven B‐ALLs.Methods and resultsIn this study we investigated a cohort of KMT2A‐rearranged B‐ALL patients with a comparison to BCR::ABL1‐rearranged B‐ALL by performing cell sorting via flow cytometry followed by FISH (fluorescence in situ hybridization) analysis on each of the sorted populations. In addition, RNA sequencing was performed on one of the sorted populations. These analyses showed that (1) multilineage involvement was present in 53% of BCR::ABL1 and 36% of KMT2A‐rearranged B‐ALL regardless of age, (2) multilineage involvement created pitfalls for residual disease monitoring, and (3) HSPC transcriptome signatures were upregulated in KMT2A‐rearranged B‐ALL with multilineage involvement.ConclusionsIn summary, multilineage involvement is common in both BCR::ABL1‐rearranged and KMT2A‐rearranged B‐ALL, which should be taken into consideration when interpreting the disease burden during the clinical course.